First Wave To Merge With ImmunogenX With Focus On Celiac Disease

 
• By Joseph Haas
  
Gluten-free
First Wave merges with ImmunogenX with a goal of producing the first celiac disease drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business